Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2010
Event: The Company mailed its 2009 Annual Report to stockholders. Excerpts from this report are included as Exhibit 99.1 to satisfy Regulation FD disclosure requirements.
Key Financial Metrics
The provided filing text does not contain specific financial data. It serves as a notification of the Annual Report mailing and incorporates excerpts by reference. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
No material changes in financial performance or operations are detailed in this specific filing text. The document references the 2009 Annual Report for comprehensive historical data but does not summarize year-over-year comparisons within the 8-K body.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the 2009 Annual Report excerpts are furnished for public disclosure under Regulation FD.
Legal Disclaimer: The information in this Current Report, including Exhibit 99.1, is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Guidance/Risks: No specific forward-looking guidance, risk factors, or contingencies are listed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Excerpts from Annual Report) for actual 2009 financial results.
- Verify the full 2009 Annual Report (Form 10-K) for complete audited financial statements and risk factors.
- Confirm the mailing date of the Annual Report to stockholders was April 23, 2010.
- Note that this 8-K filing itself does not constitute a "filed" document for liability purposes under Section 18 of the Exchange Act.